Suppliers / Hebei Jiheng Pharmaceutical

Hebei Jiheng Pharmaceutical

China Updated 9 July 2026

Hebei Jiheng Pharmaceutical is a contract manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 21 June 2024 as VAI.

2
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
3
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 21 June 2024 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3004803368
Hengshui, China Not on file

What they file, and where

Molecule Regulators Docs
Acetaminophen SFDA (Saudi Arabia), US FDA 2
Folic Acid US FDA 1

Also appears on these molecule pages

Acetaminophen contract manufacturing Paracetamol contract manufacturing

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 3 None
EMA None 2
US FDA None 1

Questions about Hebei Jiheng Pharmaceutical

Does Hebei Jiheng Pharmaceutical hold a US DMF or a CEP?
Hebei Jiheng Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Hebei Jiheng Pharmaceutical FDA-registered?
One site operated by Hebei Jiheng Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Hebei Jiheng Pharmaceutical's last inspection go?
The most recent inspection on record closed on 21 June 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Hebei Jiheng Pharmaceutical manufacture?
2 registered sites are on record, in China (China and Hengshui). Every site is listed on this page with the register it came from.
What does Hebei Jiheng Pharmaceutical make?
2 molecules are on record against Hebei Jiheng Pharmaceutical, including Acetaminophen and Folic Acid. Each links through to that molecule's full manufacturer list.
Which regulators recognise Hebei Jiheng Pharmaceutical's GMP?
Current GMP certificates are on record from EMA and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Hebei Jiheng Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 21 June 2024.

Comparable suppliers

Apitoria Pharma shares 2 molecules Granules India shares 2 molecules Specgx shares 2 molecules IOL Chemicals and Pharmaceuticals shares 2 molecules Anqiu Lu'an Pharmaceutical shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates